
Repertaxin
CAS No. 266359-83-5
Repertaxin( Repertaxin | DF 1681Y )
Catalog No. M17461 CAS No. 266359-83-5
Reparixin is a potent inhibitor of both CXCL8 receptors?CXCR1/2, it inhibits weakly?CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks?CXCR1-mediated chemotaxis (IC50=1 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 65 | In Stock |
![]() ![]() |
5MG | 110 | In Stock |
![]() ![]() |
10MG | 177 | In Stock |
![]() ![]() |
25MG | 372 | In Stock |
![]() ![]() |
50MG | 556 | In Stock |
![]() ![]() |
100MG | 791 | In Stock |
![]() ![]() |
500MG | 1575 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameRepertaxin
-
NoteResearch use only, not for human use.
-
Brief DescriptionReparixin is a potent inhibitor of both CXCL8 receptors?CXCR1/2, it inhibits weakly?CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks?CXCR1-mediated chemotaxis (IC50=1 nM).
-
DescriptionReparixin is a potent inhibitor of both CXCL8 receptors?CXCR1/2, it inhibits weakly?CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks?CXCR1-mediated chemotaxis (IC50=1 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsRepertaxin | DF 1681Y
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCXCR1| CXCR2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number266359-83-5
-
Formula Weight283.39
-
Molecular FormulaC14H21NO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 500 mg/mL; 1764.35 mM
-
SMILESCS(=O)(=O)NC(=O)[C@@H](c1ccc(CC(C)C)cc1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moriconi A, et al. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2. J Med Chem. 2007 Aug 23;50(17):3984-4002.
molnova catalog



related products
-
ML-193
ML-193 is a potent and selective GPR55 antagonist( IC50 : 221 nM).
-
Hemopressin (rat)
Bioactive endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE. Ki values are 27.76, 3.43 and 1.87 μM respectively. Potent hypotensive in vivo. Also acts as a selective CB1 receptor inverse agonist. Displays antinociceptive activity and induces hypophagia in vivo.
-
GAT-211
GAT-211 (GAT211) is a selective cannabinoid 1 receptor (CB1R) positive allosteric modulator with pKb of 7.26, Arrestin2 EC50 of 775 nM.